Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2025)
Charles River Laboratories International (CRL) recorded quarterly Income from Non-Controlling Interests of $265000.0 in Q4 2025, down 76.63% quarter-over-quarter from $1.1 million in Q3 2025, and down 64.57% on a YoY basis from $748000.0 in Q4 2024.
Charles River Laboratories International (CRL) Income from Non-Controlling Interests (2009 - 2025) Analysis & Trends
Charles River Laboratories International's Income from Non-Controlling Interests history runs 17 years deep, the most recent figure standing at $265000.0 for Q4 2025.
- In Q4 2025, Income from Non-Controlling Interests fell 64.57% year-over-year to $265000.0; the TTM figure through Dec 2025 stood at $2.2 million (down 29.57% YoY), while the FY2025 annual figure was $2.2 million, down 29.57% from the prior year.
- Income from Non-Controlling Interests was $265000.0 for Q4 2025 at Charles River Laboratories International, down from $1.1 million in the prior quarter.
- In the past five years, Income from Non-Controlling Interests ranged from a high of $2.4 million in Q3 2023 to a low of $180000.0 in Q2 2024.
- Historically, Income from Non-Controlling Interests has averaged $1.3 million across 5 years, with a median of $1.2 million in 2022.
- The sharpest annual moves came in 2021 and 2024: Income from Non-Controlling Interests jumped 3436.76% in 2021, then tumbled 92.57% in 2024.
- A 5-year view of Income from Non-Controlling Interests shows it stood at $2.2 million in 2021, then slipped by 24.59% to $1.7 million in 2022, then gained by 10.14% to $1.9 million in 2023, then sank by 59.96% to $748000.0 in 2024, then slumped by 64.57% to $265000.0 in 2025.
- The last three Income from Non-Controlling Interests figures came in at $265000.0 (Q4 2025), $1.1 million (Q3 2025), and $367000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inc. Minority (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | - |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | 5.00 Mn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | - |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | - |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | - |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | 1.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | - |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | - |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | - |
| 10 | Charles River Laboratories International | 9.26 Bn | 9.06 Bn | 744.94 Mn | 265,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 27, 2025 | 265,000.00 |
| Sep 27, 2025 | 1.13 Mn |
| Jun 28, 2025 | 367,000.00 |
| Mar 29, 2025 | 409,000.00 |
| Dec 28, 2024 | 748,000.00 |
| Sep 28, 2024 | 638,000.00 |
| Jun 29, 2024 | 180,000.00 |
| Mar 30, 2024 | 1.52 Mn |
| Dec 30, 2023 | 1.87 Mn |
| Sep 30, 2023 | 632,000.00 |
| Jul 1, 2023 | 2.42 Mn |
| Apr 1, 2023 | 823,000.00 |
| Dec 31, 2022 | 1.70 Mn |
| Sep 24, 2022 | 1.14 Mn |
| Jun 25, 2022 | 1.34 Mn |
| Mar 26, 2022 | 2.20 Mn |
| Dec 25, 2021 | 2.25 Mn |
| Sep 25, 2021 | 1.73 Mn |
| Jun 26, 2021 | 1.47 Mn |
| Mar 27, 2021 | 2.41 Mn |